A 2013 meta-analysis of randomized controlled trials found that L-carnitine therapy in patients who experienced an MI reduced the risks of all-cause mortality (-27%
How does peptide therapy differ from traditional hormone therapy
For patients who wish to reduce their cardiovascular and renal risk, SGLT-2 inhibitors are preferred, but GLP-1 receptor agonists are reasonable
Molecular mechanisms of autophagy decline during aging
Individual variation is significant, and the best approach is to monitor your own reaction patterns across different sites and favor the locations that produce the mildest responses
In clinical settings, glucose-lowering, weight loss, natriuresis, and blood pressure reduction may account for the renoprotective effects of GLP-1RAs